This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sandrin, M.S., Vaughan, H.A., Dabkowski, P.L. & McKenzie, I.F.C., IgM antibodies in human serum react predominantly with gal(α1–3)gal epitopes. Proc. natn. Acad. Sci. U.S.A. 90, 11391–11395 (1993).
Bach, F.H., Turman, M.A., Vercellotti, G.M., Platt, J.L. & Dalmasso, A.P. Accommodation: A working paradigm for progressing toward discordant xenografting. Transplantn Proc. 23, 205–208 (1991).
Baldwin, W.M., Pruitt, S.K., Brauer, R.B., Daha, M.R. & Sanfilippo, F. Complement in organ transplantation. Transplantation 59, 797–808 (1995).
Ryan, U.S. Complement inhibition: The sine qua non of xenotransplantation?. Xeno 2, 19–22 (1994).
Thomas, L.J. & Ryan, U.S. Immunological consequences of organ transplantation: Implications for therapeutic development. J. Heart Lung Transplantn (in the press).
Dalmasso, A.P., Vercellotti, G.M., Platt, J.L. & Bach, F.H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: Potential for prevention of xenograft hyperacute rejection. Transplantation 32, 530–533 (1991).
McCurry, K.R. et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med. 1, 423–427 (1995).
Cozzi, E. & White, D.J.G. The generation of transgenic pigs as potential organ donors for man. Nature Med. 1, 964–966 (1995).
Foder, W.L. & Squinto, S.P. Engineering of transgenic pigs for xenogeneic organ transplantation. Xeno 3, 23–25 (1995).
Weisman, H.F. et al. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146–151 (1990).
Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52, 868–873 (1992).
Xia, W. et al. Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1. Transplantn Proc. 24, 479–480 (1992).
Xia, W., Fearon, D.T. & Kirkman, R.L. Effect on repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. Transplantn Proc. 25, 410–411 (1993).
Pruitt, S.K. et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363–370 (1994).
Candinas, D. et al. Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation. Transplantn Proc. (in the press).
Pruitt, S.K. et al. Continuous complement (C) inhibition using soluble complement receptor type 1 (sCRI): Effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts (Xgs). Transplantn Proc. (in the press).
Bannett, A.D., McAlack, R.F., Raja, R., Baquero, A. & Morris, M. Experiences with known ABO-mismatched renal transplants. Transplantn Proc. XIX, 4543–4546 (1987).
Alexandre, G.P.J. et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplantn Proc. XIX, 4538–4542 (1987).
Ryan, U.S., ed. Endothelial Cells I–III (CRCBoca Raton, Florida, 1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ryan, U. Complement inhibitory therapeutics and xenotransplantation. Nat Med 1, 967–968 (1995). https://doi.org/10.1038/nm0995-967
Issue Date:
DOI: https://doi.org/10.1038/nm0995-967
This article is cited by
-
Infection of human cells by an endogenous retrovirus of pigs
Nature Medicine (1997)
-
High efficiency DNA delivery into swine oocytes and embryos by electronic pulse delivery (EPD)
Cell Research (1997)